◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Kaken Pharmaceutical Co., Ltd. (4521)
来自官方财务报表的收入、利润与现金流历史。
Healthcare · 华尔街（美国） · 最近更新： 2026-10-02
Kaken Pharmaceutical Co., Ltd. produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.
关键数据
- 市值: JPY 143 billion
- 收入（截至 2026-03-31 财年）: JPY 76.9B
- 净利润: JPY 2.1B
- 毛利率: 52.0%
- 净利率: 2.8%
查看交互式图表与完整报表 →
估值模型 (DCF) →
年度利润表
| 利润表 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|
| 总收入 | JPY 76.9B | JPY 94.0B | JPY 72.0B | JPY 73.0B |
| 毛利 | JPY 40.0B | JPY 58.5B | JPY 38.5B | JPY 39.6B |
| 营业利润（EBIT） | (JPY 897M) | JPY 21.0B | JPY 9.5B | JPY 8.0B |
| 净利 | JPY 2.1B | JPY 13.9B | JPY 8.0B | JPY 5.4B |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 4521 交互式查看器。 /companies/us/4521
类似公司
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.